Adi S. Virji

538 total citations
11 papers, 448 citations indexed

About

Adi S. Virji is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Adi S. Virji has authored 11 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Pharmacology. Recurrent topics in Adi S. Virji's work include Estrogen and related hormone effects (2 papers), Sirtuins and Resveratrol in Medicine (2 papers) and Inflammatory mediators and NSAID effects (2 papers). Adi S. Virji is often cited by papers focused on Estrogen and related hormone effects (2 papers), Sirtuins and Resveratrol in Medicine (2 papers) and Inflammatory mediators and NSAID effects (2 papers). Adi S. Virji collaborates with scholars based in United States, United Kingdom and Mexico. Adi S. Virji's co-authors include T.M.A. ElAttar, P Howard, A H Beckett, Tarik Attar, Jianghong Zhang, Carole McArthur, Charles M. Cobb, John W. Rapley, Karen Williams and Simon R. MacNeill and has published in prestigious journals such as Journal Of Clinical Periodontology, American Journal of Clinical Pathology and Journal of Pharmacy and Pharmacology.

In The Last Decade

Adi S. Virji

11 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adi S. Virji United States 8 190 134 99 96 65 11 448
Freya Wolter Germany 6 289 1.5× 88 0.7× 79 0.8× 268 2.8× 29 0.4× 6 544
Reza Entezari Heravi Iran 7 192 1.0× 113 0.8× 60 0.6× 26 0.3× 47 0.7× 11 567
Jean‐Claude Izard France 8 278 1.5× 96 0.7× 84 0.8× 270 2.8× 16 0.2× 9 540
Sandra Ulrich Germany 11 269 1.4× 51 0.4× 46 0.5× 142 1.5× 22 0.3× 14 494
Evgeny A. Rogozin United States 8 298 1.6× 185 1.4× 127 1.3× 33 0.3× 15 0.2× 9 552
Mohd Fahad Ullah India 7 315 1.7× 149 1.1× 84 0.8× 20 0.2× 34 0.5× 8 629
Madhumitha Kedhari Sundaram Saudi Arabia 12 421 2.2× 72 0.5× 118 1.2× 45 0.5× 35 0.5× 15 637
Paula Ferrer Spain 6 259 1.4× 63 0.5× 35 0.4× 112 1.2× 12 0.2× 6 431
Michaela Miksits Austria 8 168 0.9× 75 0.6× 93 0.9× 242 2.5× 16 0.2× 10 435

Countries citing papers authored by Adi S. Virji

Since Specialization
Citations

This map shows the geographic impact of Adi S. Virji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adi S. Virji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adi S. Virji more than expected).

Fields of papers citing papers by Adi S. Virji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adi S. Virji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adi S. Virji. The network helps show where Adi S. Virji may publish in the future.

Co-authorship network of co-authors of Adi S. Virji

This figure shows the co-authorship network connecting the top 25 collaborators of Adi S. Virji. A scholar is included among the top collaborators of Adi S. Virji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adi S. Virji. Adi S. Virji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Virji, Adi S., et al.. (2002). Can application of exogenous fibronectin enhance periodontal regeneration?. Journal Of Clinical Periodontology. 29(5). 440–447. 3 indexed citations
3.
ElAttar, T.M.A. & Adi S. Virji. (2001). Effect of tea polyphenols on growth of oral squamous carcinoma cells in vitro.. PubMed. 20(5B). 3459–65. 48 indexed citations
4.
ElAttar, T.M.A. & Adi S. Virji. (2000). The inhibitory effect of curcumin, genistein, quercetin and cisplatin on the growth of oral cancer cells in vitro.. PubMed. 20(3A). 1733–8. 138 indexed citations
5.
ElAttar, T.M.A. & Adi S. Virji. (2000). The effect of red wine and its components on growth and proliferation of human oral squamous carcinoma cells.. PubMed. 19(6B). 5407–14. 83 indexed citations
6.
ElAttar, T.M.A. & Adi S. Virji. (1999). Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation. Anti-Cancer Drugs. 10(2). 187–194. 124 indexed citations
7.
ElAttar, T.M.A. & Adi S. Virji. (1999). Biphasic action of vitamin E on the growth of human oral squamous carcinoma cells.. PubMed. 19(1A). 365–8. 10 indexed citations
8.
Attar, Tarik & Adi S. Virji. (1998). Effects of indomethacin, cisplatin and delta 12-prostaglandin J2 on growth of oral squamous carcinoma cells.. PubMed. 17(6D). 4399–402. 4 indexed citations
9.
ElAttar, T.M.A. & Adi S. Virji. (1997). Inhibition of growth in oral squamous carcinoma cells by cyclopentenone prostaglandins: comparison with chemotherapeutic agents. Prostaglandins Leukotrienes and Essential Fatty Acids. 56(6). 461–465. 8 indexed citations
10.
Virji, Adi S., et al.. (1980). Erroneously Low Results Due to High Nonspecific Binding Encountered with a Radioassay Kit That Measures “True” Serum Vitamin B12. American Journal of Clinical Pathology. 74(2). 209–213. 8 indexed citations
11.
Beckett, A H, et al.. (1967). Micelles as simple models of drug receptors. Journal of Pharmacy and Pharmacology. 19(12). 827–836. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026